Lupus (Systemic Lupus Erythematosus)

Overview

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune condition in which the immune system becomes dysregulated and can attack the body’s own tissues. Unlike illnesses confined to a single organ, SLE is considered a multisystem disease because it may affect the skin, joints, kidneys, blood cells, heart, lungs, nervous system, and blood vessels. Its course is often marked by periods of increased disease activity, sometimes called flares, alternating with quieter phases. Symptoms vary widely, but common features include fatigue, joint pain or swelling, rashes, fever, photosensitivity, mouth ulcers, and Raynaud-like symptoms.

Lupus is clinically significant because it can range from relatively mild disease to serious organ-threatening involvement, particularly when the kidneys, brain, cardiovascular system, or hematologic system are affected. Research indicates that SLE disproportionately affects women, especially during childbearing years, and is more common and often more severe in certain racial and ethnic populations, including Black, Hispanic/Latina, Asian, and Indigenous groups in many regions. This variability reflects a complex interplay of genetic susceptibility, hormonal influences, environmental triggers, and immune dysfunction.

From a biologic standpoint, SLE is associated with loss of immune tolerance, production of autoantibodies such as antinuclear antibodies (ANA), immune complex formation, and inflammation that can damage tissues over time. However, lupus is not a single-pattern illness: one person may have mostly skin and joint symptoms, while another may present with nephritis or neurologic involvement. Because there is no single definitive test for all cases, diagnosis typically depends on a combination of symptoms, physical findings, laboratory markers, and classification criteria used by specialists.

Lupus also carries a broader health burden beyond acute inflammation. Studies suggest that people with SLE may face increased risks related to cardiovascular disease, osteoporosis, infections, pregnancy complications, medication side effects, and reduced quality of life. For that reason, contemporary care often emphasizes not only control of immune activity, but also long-term monitoring, prevention of complications, and coordinated care with rheumatology and other specialists. Anyone with symptoms suggestive of lupus or an established diagnosis benefits from ongoing evaluation by qualified healthcare professionals, since disease patterns and risks can change over time.